Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+T-cell repertoire

被引:46
作者
Bos, R
van Duikeren, S
van Hall, T
Kaaijk, P
Taubert, R
Kyewski, B
Klein, L
Melief, CJM
Offringa, R
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Tumor Immunol Grp, NL-2300 RC Leiden, Netherlands
[2] German Canc Res Ctr, Tumor Immunol Program, D-6900 Heidelberg, Germany
[3] Res Inst Mol Pathol, A-1030 Vienna, Austria
关键词
D O I
10.1158/0008-5472.CAN-05-0666
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A variety of antigens that display a highly tissue-specific expression pattern have recently found to be also expressed in medullary thymic epithelial cells (mTEC). This unique feature of mTEC plays an important role in preventing hazardous autoimmune responses through thymic tolerization of T-cell subsets directed against autoantigens but could also limit the possibility of exploiting tumor-associated antigens for immune-mediated targeting of cancers. Our present study shows that expression of carcinoembryonic antigen (CEA) in thymic epithelial cells of CEA-transgenic mice results in tolerization of a major fraction of the CD4(+) T-cell repertoire against this antigen, thereby markedly limiting the effect of CEA-specific immunization against CEA-overexpressing tumors. The expression of CEA in mTEC of CEA-transgenic mice is mirrored by its expression in human mTEC, arguing that promiscuous gene expression in these thymic stromal cells needs to be considered as a potential hurdle for immunotherapies of cancer that target tissue-specific autoantigens.
引用
收藏
页码:6443 / 6449
页数:7
相关论文
共 30 条
[21]   Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans [J].
McConkey, SJ ;
Reece, WHH ;
Moorthy, VS ;
Webster, D ;
Dunachie, S ;
Butcher, G ;
Vuola, JM ;
Blanchard, TJ ;
Gothard, P ;
Watkins, K ;
Hannan, CM ;
Everaere, S ;
Brown, K ;
Kester, KE ;
Cummings, J ;
Williams, J ;
Heppner, DG ;
Pathan, A ;
Flanagan, K ;
Arulanantham, N ;
Roberts, MTM ;
Roy, M ;
Smith, GL ;
Schneider, J ;
Peto, T ;
Sinden, RE ;
Gilbert, SC ;
Hill, AVS .
NATURE MEDICINE, 2003, 9 (06) :729-735
[22]   CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ [J].
Mumberg, D ;
Monach, PA ;
Wanderling, S ;
Philip, M ;
Toledano, AY ;
Schreiber, RD ;
Schreiber, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8633-8638
[23]   Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors [J].
Ossendorp, F ;
Mengedé, E ;
Camps, M ;
Filius, R ;
Melief, CJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :693-702
[24]   Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells [J].
Overwijk, WW ;
Theoret, MR ;
Finkelstein, SE ;
Surman, DR ;
de Jong, LA ;
Vyth-Dreese, FA ;
Dellemijn, TA ;
Antony, PA ;
Spiess, PJ ;
Palmer, DC ;
Heimann, DM ;
Klebanoff, CA ;
Yu, ZY ;
Hwang, LN ;
Feigenbaum, L ;
Kruisbeek, AM ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :569-580
[25]   Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost [J].
Park, SH ;
Yang, SH ;
Lee, CG ;
Youn, JW ;
Chang, J ;
Sung, YC .
VACCINE, 2003, 21 (31) :4555-4564
[26]  
Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO
[27]  
2-F
[28]   GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR HUMAN CARCINOEMBRYONIC ANTIGEN EPITOPES FROM PATIENTS IMMUNIZED WITH RECOMBINANT VACCINIA-CEA VACCINE [J].
TSANG, KY ;
ZAREMBA, S ;
NIERODA, CA ;
ZHU, MZ ;
HAMILTON, JM ;
SCHLOM, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (13) :982-990
[29]   Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens [J].
van der Burg, SH ;
Kwappenberg, KMC ;
O'Neill, T ;
Brandt, RMP ;
Melief, CJM ;
Hickling, JK ;
Offringa, R .
VACCINE, 2001, 19 (27) :3652-3660
[30]   A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice [J].
Xiang, R ;
Primus, FJ ;
Ruehlmann, JM ;
Niethammer, AG ;
Silletti, S ;
Lode, HN ;
Dolman, CS ;
Gillies, SD ;
Reisfeld, RA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4560-4565